Details for New Drug Application (NDA): 211145

NDA 211145 describes URSODIOL, which is a drug marketed by Abhai Llc, Amneal Pharms Co, Aurobindo Pharma Ltd, Chartwell Rx, Epic Pharma, Hibrow Hlthcare, Impax Labs Inc, Lannett Co Inc, Lgm Pharma, Quagen, Rising, Rk Pharma, Strides Pharma, Teva Pharms, Zydus Lifesciences, Epic Pharma Llc, Glenmark Pharms Ltd, Ph Health, and Teva Pharms Usa, and is included in twenty-two NDAs. It is available from twenty-eight suppliers. Additional details are available on the URSODIOL profile page.

The generic ingredient in URSODIOL is ursodiol. There are eight drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the ursodiol profile page.

Summary for 211145

Tradename:	URSODIOL
Applicant:	Zydus Lifesciences
Ingredient:	ursodiol
Patents:	0

Pharmacology for NDA: 211145

Suppliers and Packaging for NDA: 211145

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
URSODIOL	ursodiol	TABLET;ORAL	211145	ANDA	American Health Packaging	60687-527	60687-527-21	30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-527-21) / 1 TABLET in 1 BLISTER PACK (60687-527-11)
URSODIOL	ursodiol	TABLET;ORAL	211145	ANDA	Zydus Pharmaceuticals (USA) Inc.	70710-1127	70710-1127-1	100 TABLET in 1 BOTTLE (70710-1127-1)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	250MG
Approval Date:	Oct 30, 2018	TE:	AB	RLD:	No

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	500MG
Approval Date:	Oct 30, 2018	TE:	AB	RLD:	No

Complete Access Available with Subscription